Sotera Health (SHC) Expected to Post Quarterly Earnings on Tuesday

Key Points

• Sotera Health is expected to report Q3 2026 results on November 3, with analysts forecasting earnings of $0.2687 per share and revenue of $319.86 million. Full-year 2026 EPS guidance is $0.950–$1.010.
• The company’s latest quarter exceeded expectations, posting $0.26 EPS versus the $0.24 consensus and $321.38 million in revenue, up 9.2% year over year.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $21.38, while insiders have sold approximately $24 million of shares over the past 90 days.

Sotera Health (NASDAQ:SHC - Get Free Report) will likely be releasing its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect the company to post earnings of $0.2687 per share and revenue of $319.86 million for the quarter. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Individuals may visit the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 9:00 AM ET.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%. The business had revenue of $321.38 million for the quarter, compared to analysts' expectations of $309.70 million. During the same quarter in the previous year, the business posted $0.20 EPS. Sotera Health's revenue for the quarter was up 9.2% on a year-over-year basis. On average, analysts expect Sotera Health to post $0.87 EPS for the current fiscal year and $0.95 EPS for the next fiscal year.

Sotera Health Price Performance

NASDAQ SHC opened at $18.39 on Tuesday. The business has a 50 day simple moving average of $18.56 and a 200 day simple moving average of $17.05. Sotera Health has a 52-week low of $13.09 and a 52-week high of $19.85. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. The stock has a market cap of $5.25 billion, a price-to-earnings ratio of 21.29 and a beta of 1.85.

Analysts Set New Price Targets

Several brokerages have recently issued reports on SHC. Wall Street Zen raised shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research report on Sunday. Citigroup upped their target price on shares of Sotera Health from $23.00 to $25.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Piper Sandler reiterated an "overweight" rating and set a $25.00 target price on shares of Sotera Health in a report on Tuesday, September 8th. Weiss Ratings downgraded Sotera Health from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Friday. Finally, JPMorgan Chase & Co. restated an "underweight" rating and issued a $17.00 price target on shares of Sotera Health in a report on Wednesday, October 14th. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $21.38.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, insider Michael Rutz sold 150,000 shares of the business's stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the sale, the insider directly owned 334,279 shares of the company's stock, valued at $6,297,816.36. The trade was a 30.97% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Chairman Michael Petras, Jr. sold 850,000 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares of the company's stock, valued at approximately $73,433,770.50. This represents a 17.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 1,294,515 shares of company stock valued at $23,999,528 in the last 90 days. 15.36% of the stock is currently owned by corporate insiders.

Sotera Health Company Profile

Sotera Health Company NASDAQ: SHC is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.

The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.